Literature DB >> 24126457

International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Nancy Agmon-Levin1, Jan Damoiseaux, Cees Kallenberg, Ulrich Sack, Torsten Witte, Manfred Herold, Xavier Bossuyt, Lucille Musset, Ricard Cervera, Aresio Plaza-Lopez, Carlos Dias, Maria José Sousa, Antonella Radice, Catharina Eriksson, Olof Hultgren, Markku Viander, Munther Khamashta, Stephan Regenass, Luis Eduardo Coelho Andrade, Allan Wiik, Angela Tincani, Johan Rönnelid, Donald B Bloch, Marvin J Fritzler, Edward K L Chan, I Garcia-De La Torre, Konstantin N Konstantinov, Robert Lahita, Merlin Wilson, Olli Vainio, Nicole Fabien, Renato Alberto Sinico, Pierluigi Meroni, Yehuda Shoenfeld.   

Abstract

Anti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases, and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the demand for ANA testing increased, alternative techniques were developed challenging the classic IIFA. These alternative platforms differ in their antigen profiles, sensitivity and specificity, raising uncertainties regarding standardisation and interpretation of incongruent results. Therefore, an international group of experts has created recommendations for ANA testing by different methods. Two groups of experts participated in this initiative. The European autoimmunity standardization initiative representing 15 European countries and the International Union of Immunologic Societies/World Health Organization/Arthritis Foundation/Centers for Disease Control and Prevention autoantibody standardising committee. A three-step process followed by a Delphi exercise with closed voting was applied. Twenty-five recommendations for determining ANA (1-13), anti-double stranded DNA antibodies (14-18), specific antibodies (19-23) and validation of methods (24-25) were created. Significant differences between experts were observed regarding recommendations 24-25 (p<0.03). Here, we formulated recommendations for the assessment and interpretation of ANA and associated antibodies. Notably, the roles of IIFA as a reference method, and the importance of defining nuclear and cytoplasmic staining, were emphasised, while the need to incorporate alternative automated methods was acknowledged. Various approaches to overcome discrepancies between methods were suggested of which an improved bench-to-bedside communication is of the utmost importance. These recommendations are based on current knowledge and can enable harmonisation of local algorithms for testing and evaluation of ANA and related autoantibodies. Last but not least, new more appropriate terminologies have been suggested.

Entities:  

Keywords:  Autoantibodies; Autoimmunity; Sjøgren's Syndrome; Systemic Lupus Erythematosus

Mesh:

Substances:

Year:  2013        PMID: 24126457     DOI: 10.1136/annrheumdis-2013-203863

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  134 in total

Review 1.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

2.  Analytical variability in the determination of anti-double-stranded DNA antibodies: the strong need of a better definition of the old and new tests.

Authors:  Maria Infantino; M Manfredi; M Merone; V Grossi; M Benucci; F Li Gobbi; F Bandinelli; A Damiani; P Soda
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

Review 3.  Autoimmune diagnostics: the technology, the strategy and the clinical governance.

Authors:  Nicola Bizzaro; Renato Tozzoli; Danilo Villalta
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

4.  Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus.

Authors:  Chelsea Bentow; Gabriella Lakos; Rachel Rosenblum; Cassandra Bryant; Andrea Seaman; Michael Mahler
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

5.  Antinuclear antibodies detection: A comparative study between automated recognition and conventional visual interpretation.

Authors:  ZhiYan Li; RuiLin Han; ZhenLin Yan; LiJuan Li; ZhenRu Feng
Journal:  J Clin Lab Anal       Date:  2018-07-20       Impact factor: 2.352

6.  Anti-nuclear antibody screening using HEp-2 cells.

Authors:  Carol Buchner; Cassandra Bryant; Anna Eslami; Gabriella Lakos
Journal:  J Vis Exp       Date:  2014-06-23       Impact factor: 1.355

7.  The spectrum between antiphospholipid syndrome and systemic lupus erythematosus.

Authors:  Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2014-03       Impact factor: 2.980

Review 8.  [Differentiated laboratory diagnostics of rheumatic diseases].

Authors:  C Specker
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

9.  Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.

Authors:  M Frodlund; J Wetterö; C Dahle; Ö Dahlström; T Skogh; J Rönnelid; C Sjöwall
Journal:  Clin Exp Immunol       Date:  2019-12-19       Impact factor: 4.330

10.  [Immune diagnostics in rheumatology].

Authors:  R Gruber; S Borgmann
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.